PATENT CLAIM ANALYSIS

Application Number: 15750378
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "004700"]

Abstract:
The present invention is intended to provide a nose drop having high absorption of peptide hormone oxytocin or an acid addition salt thereof, or a derivative thereof through nasal mucosa and little safety concern. The present invention is a pharmaceutical composition for administration to nasal mucosa containing oxytocin or an acid addition salt thereof, or a derivative thereof and a carboxyvinyl polymer, characterized by having an osmotic pressure ratio less than 1.

Claim (Index 6):
The pharmaceutical composition for administration to nasal mucosa according to  claim 1 , wherein 0.01-20 mM of the salt is contained in the pharmaceutical composition for administration to nasal mucosa.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.60417
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10201303', '09446276', '12226287', '10489655', '13929100']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7754171632381877
- 35 USC 102 Novelty (BERT): 0.4842009027133511
- Combined Prediction Score: 0.746295537185704
- Mean Citation Score: 183.691262
- Max Citation Score: 198.73273
- Similarity Product: 148.68003044112982

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test